Canakinumab Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with canakinumab
R
- RabAvert (rabies vaccine, purified chick embryo cell)
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- Rajani (drospirenone / ethinyl estradiol / levomefolate calcium)
- Rapamune (sirolimus)
- Raptiva (efalizumab)
- Rasuvo (methotrexate)
- ravulizumab
- Rayos (prednisone)
- RE-PB Hyos Elixir (atropine / hyoscyamine / phenobarbital / scopolamine)
- React (levonorgestrel)
- Reclipsen (desogestrel / ethinyl estradiol)
- Recombivax HB (hepatitis b pediatric vaccine)
- Recombivax HB Adult (hepatitis b adult vaccine)
- Recombivax HB Dialysis Formulation (hepatitis b adult vaccine)
- Recombivax HB Pediatric / Adolescent (hepatitis b pediatric vaccine)
- RediTrex (methotrexate)
- Relacon-HC (chlorpheniramine / hydrocodone / phenylephrine)
- Relacon-HC NR (chlorpheniramine / hydrocodone / phenylephrine)
- Relasin-HC (chlorpheniramine / hydrocodone / phenylephrine)
- Relasin-HCX (guaifenesin / hydrocodone)
- Remicade (infliximab)
- Renflexis (infliximab)
- Reprexain (hydrocodone / ibuprofen)
- Respbid (theophylline)
- Restora (lactobacillus casei / omega-3 polyunsaturated fatty acids)
- Restora Rx (folic acid / lactobacillus casei)
- Rethymic (allogeneic processed thymus tissue)
- Retrovir (zidovudine)
- Revlimid (lenalidomide)
- Rezira (hydrocodone / pseudoephedrine)
- Rezyst (bifidobacterium infantis / lactobacillus acidophilus)
- ReZyst IM (bifidobacterium infantis / lactobacillus acidophilus)
- Rheumatrex Dose Pack (methotrexate)
- Rhuzdah (ethinyl estradiol / norethindrone)
- Riabni (rituximab)
- ribociclib
- rilonacept
- Rindal HD Plus (chlorpheniramine / hydrocodone / phenylephrine)
- Rindal HPD (diphenhydramine / hydrocodone / phenylephrine)
- Rindal-HD (chlorpheniramine / hydrocodone / phenylephrine)
- Rinvoq (upadacitinib)
- Rinvoq LQ (upadacitinib)
- Risa-Bid (lactobacillus acidophilus)
- risankizumab
- RisaQuad (lactobacillus acidophilus)
- RisaQuad 2 (lactobacillus acidophilus)
- ritlecitinib
- Rituxan (rituximab)
- Rituxan Hycela (hyaluronidase / rituximab)
- rituximab
- rivaroxaban
- Rivelsa (ethinyl estradiol / levonorgestrel)
- Rocephin IM Convenience Kit (ceftriaxone / lidocaine)
- roflumilast
- Rolatuss with Hydrocodone (hydrocodone / pheniramine / phenylephrine / phenylpropanolamine / pyrilamine)
- romidepsin
- ropeginterferon alfa-2b
- ropivacaine / sufentanil
- Rotarix (rotavirus vaccine)
- RotaShield (rotavirus vaccine)
- RotaTeq (rotavirus vaccine)
- rotavirus vaccine
- Roxicet (acetaminophen / oxycodone)
- Roxicodone (oxycodone)
- Roxicodone Intensol (oxycodone)
- Roxilox (acetaminophen / oxycodone)
- Roxiprin (aspirin / oxycodone)
- RoxyBond (oxycodone)
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- Ru-Tuss with Hydrocodone (hydrocodone / pheniramine / phenylephrine / phenylpropanolamine / pyrilamine)
- rubella virus vaccine
- Rubraca (rucaparib)
- rucaparib
- Ruxience (rituximab)
- ruxolitinib
- Rydapt (midostaurin)
- Rystiggo (rozanolixizumab)
- Rytelo (imetelstat)
- Rythmol (propafenone)
- Rythmol SR (propafenone)
More about canakinumab
- canakinumab consumer information
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.